Vicki Wheelock

2.3k total citations
21 papers, 563 citations indexed

About

Vicki Wheelock is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Vicki Wheelock has authored 21 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 9 papers in Cellular and Molecular Neuroscience and 5 papers in Cognitive Neuroscience. Recurrent topics in Vicki Wheelock's work include Neurological disorders and treatments (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Genetic Neurodegenerative Diseases (8 papers). Vicki Wheelock is often cited by papers focused on Neurological disorders and treatments (11 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Genetic Neurodegenerative Diseases (8 papers). Vicki Wheelock collaborates with scholars based in United States, China and United Kingdom. Vicki Wheelock's co-authors include Karen A. Sigvardt, Christopher I. Higginson, Conrad T. E. Pappas, David S. King, J. M. Hurtado, Leonid L. Rubchinsky, Teresa Tempkin, Jan A. Nolta, Geralyn Annett and Heather Stewart and has published in prestigious journals such as Brain, Neurology and Journal of Neurophysiology.

In The Last Decade

Vicki Wheelock

20 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicki Wheelock United States 12 332 230 170 131 96 21 563
Jeffrey Politsky United States 6 209 0.6× 255 1.1× 192 1.1× 121 0.9× 97 1.0× 6 493
Tillmann Weber Germany 15 87 0.3× 186 0.8× 69 0.4× 158 1.2× 78 0.8× 25 489
Guohe Tan China 9 105 0.3× 140 0.6× 72 0.4× 270 2.1× 188 2.0× 22 659
Roberta Morace Italy 16 204 0.6× 163 0.7× 285 1.7× 59 0.5× 96 1.0× 41 710
Christiana Ossig Germany 11 274 0.8× 91 0.4× 60 0.4× 87 0.7× 27 0.3× 13 437
Valeria Elisa Contarino Italy 14 207 0.6× 86 0.4× 157 0.9× 47 0.4× 65 0.7× 29 482
Ajit Kale United States 8 235 0.7× 173 0.8× 27 0.2× 160 1.2× 35 0.4× 12 520
Francis Odeh Norway 13 103 0.3× 102 0.4× 69 0.4× 55 0.4× 100 1.0× 26 455
Katya Kotschet Australia 14 615 1.9× 184 0.8× 176 1.0× 130 1.0× 53 0.6× 17 893

Countries citing papers authored by Vicki Wheelock

Since Specialization
Citations

This map shows the geographic impact of Vicki Wheelock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki Wheelock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki Wheelock more than expected).

Fields of papers citing papers by Vicki Wheelock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki Wheelock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki Wheelock. The network helps show where Vicki Wheelock may publish in the future.

Co-authorship network of co-authors of Vicki Wheelock

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki Wheelock. A scholar is included among the top collaborators of Vicki Wheelock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki Wheelock. Vicki Wheelock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Higginson, Christopher I., et al.. (2023). Sex differences in Parkinson disease-associated episodic memory and processing speed deficits. Journal of the International Neuropsychological Society. 29(9). 813–820. 3 indexed citations
2.
Rosser, Anne, Monica Busse, William Gray, et al.. (2022). Translating cell therapies for neurodegenerative diseases: Huntington’s disease as a model disorder. Brain. 145(5). 1584–1597. 16 indexed citations
3.
Wang, Zhaoxia, Yining Huang, Sarah Farias, et al.. (2021). A Retrospective Study of Pimavanserin in Patients with Parkinson’s Disease: a Single-center Experience. (2083). Neurology. 96(15_supplement). 2 indexed citations
4.
Davis, Marie Y., Vicki Wheelock, Lauren Talman, et al.. (2021). Subdural Hematoma as a Serious Complication of Huntington’s Disease: An Observational Study. Journal of Huntington s Disease. 10(3). 385–390.
5.
Zhang, Lin, et al.. (2020). COVID-19: Neuroinvasiveness, Neurotropism and Neurovirulence. 6(S1). S24–S31. 2 indexed citations
6.
Yuan, Mei, Vicki Wheelock, Sarah Farias, et al.. (2017). Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study. Brain and Behavior. 7(6). e00639–e00639. 15 indexed citations
7.
8.
Fink, Kyle D., Peter Deng, Joseph S. Anderson, et al.. (2016). Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts. Cell Transplantation. 25(4). 677–686. 50 indexed citations
9.
Fink, Kyle D., Peter Deng, Heather Stewart, et al.. (2015). Developing Stem Cell Therapies for Juvenile and Adult-Onset Huntington's Disease. Regenerative Medicine. 10(5). 623–646. 36 indexed citations
10.
Higginson, Christopher I., et al.. (2014). Subjective Cognitive Complaints in Parkinson Disease Without Dementia: A Preliminary Study. Applied Neuropsychology Adult. 22(4). 287–292. 29 indexed citations
11.
Goldenholz, Daniel M., Victoria S.S. Wong, Lisa M. Bateman, et al.. (2012). Treatment of γ-Aminobutyric AcidBReceptor–Antibody Autoimmune Encephalitis With Oral Corticosteroids. Archives of Neurology. 69(8). 1061–3. 3 indexed citations
12.
Olson, Scott D., Kari Pollock, Amal Kambal, et al.. (2011). Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease. Molecular Neurobiology. 45(1). 87–98. 64 indexed citations
13.
Higginson, Christopher I., et al.. (2011). Predictors of HVOT Performance in Parkinson's Disease. Applied Neuropsychology. 18(3). 210–215. 6 indexed citations
14.
Wong, Victoria S.S., et al.. (2011). Cerebral Venous Sinus Thrombosis Presenting With Auditory Hallucinations and Illusions. Cognitive and Behavioral Neurology. 24(1). 40–42. 5 indexed citations
15.
Higginson, Christopher I., et al.. (2008). Cognitive deficits in essential tremor consistent with frontosubcortical dysfunction. Journal of Clinical and Experimental Neuropsychology. 30(7). 760–765. 56 indexed citations
16.
Higginson, Christopher I., et al.. (2008). The clinical significance of neuropsychological changes following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 31(1). 65–72. 23 indexed citations
17.
Franz, Elizabeth A., et al.. (2005). Dopamine dependency of cognitive switching and response repetition effects in Parkinson's patients. Neuropsychologia. 43(14). 1990–1999. 36 indexed citations
18.
Higginson, Christopher I., et al.. (2005). Recognition Memory in Parkinson’s Disease With and Without Dementia: Evidence Inconsistent with the Retrieval Deficit Hypothesis. Journal of Clinical and Experimental Neuropsychology. 27(4). 516–528. 62 indexed citations
19.
Hurtado, J. M., Leonid L. Rubchinsky, Karen A. Sigvardt, Vicki Wheelock, & Conrad T. E. Pappas. (2004). Temporal Evolution of Oscillations and Synchrony in GPi/Muscle Pairs in Parkinson's Disease. Journal of Neurophysiology. 93(3). 1569–1584. 70 indexed citations
20.
Higginson, Christopher I., et al.. (2003). The relationship between executive function and verbal memory in Parkinson’s disease. Brain and Cognition. 52(3). 343–352. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey Politsky Breakdown of academic impact, for papers by Tillmann Weber Breakdown of academic impact, for papers by Guohe Tan Breakdown of academic impact, for papers by Roberta Morace Breakdown of academic impact, for papers by Christiana Ossig Breakdown of academic impact, for papers by Valeria Elisa Contarino Breakdown of academic impact, for papers by Ajit Kale Breakdown of academic impact, for papers by Francis Odeh Breakdown of academic impact, for papers by Katya Kotschet
Rankless by CCL
2026